| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.21B | +35.2% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | +72.5% |
| Gross margin | 49.6% | Net margin 14.8% |
| Revenue Q/Q | -1.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 50.4% |
| R&D | ¥0.03B | 12.2% |
| SG&A | ¥0.04B | 19.8% |
| Tax & other | ¥0.00B | 1.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
濮阳惠成 ・ 万孚生物 ・ 首华燃气 ・ 蓝海华腾 ・ 赛升药业 ・ 东杰智能 ・ 蓝晓科技 ・ 恒锋工具 ・ 光智科技 ・ 华自科技 ・ 通合科技 ・ 华图山鼎
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies